Fundraising Fox

Karl Handelsman

InvestorFounder

Founder and Managing Partner at Codon Capital · Board director at Bonum Therapeutics

San Francisco, California

Writes $100K – $5M checks · typically $1.5M

FoundedBonum Therapeutics

About

Karl Handelsman is founder and managing partner of Codon Capital, where he invests in early-stage pre-clinical therapeutics and synthetic biology companies. His investment portfolio includes multiple companies that achieved acquisitions or IPOs within 18 months of founding. His experience spans biotech company formation and early-stage investing.

Board director at Bonum Therapeutics

Intro paths

→

In turn, Karl can intro founders to Bonum Therapeutics's investors below.

Bonum Therapeutics's investors · 6

3x5 PartnersPortlandCodon CapitalSan FranciscoDigitalis VenturesNew York · $100K – $10M checksRiverVest Venture PartnersSt. Louis · $500K – $3M checks · since 2026Roche Venture FundBasel · $648K – $3.2M checksVivo CapitalPalo Alto · $10M – $50M checks

Co-founders at Bonum Therapeutics

JMJohn Mulligan
John MulliganExecutive Officer, Director, Promoter
NPNeela Patel
Neela PatelExecutive Officer
DH
Diane HollenbaughExecutive Officer

Experience

  1. Codon CapitalFounder & Investorcurrent2013 — presentSan Francisco Bay Area- home base
  2. UCSFCatalyst Advisory Panelcurrent2013 — presentSan Francisco Bay Area
  3. UCSFLean Launchpad for Therapeutics/Tools Instructor2013 — 2016UCSF
  4. Stanford UniversitySPARK Selection Committeecurrent2013 — presentPalo Alto, CA
  5. Life Science AngelsMember2014 — 2025San Francisco Bay Area
  6. GenentechSenior Advisor, Roche Venture Fund2016 — 2021South San Francisco CA
  7. California Inst. for Regenerative MedicineMentor2013 — 2016San Francisco Bay Area
  8. CMEA CapitalGeneral Partner Emeritus2013 — 2014San Francisco Bay Area
  9. CMEA CapitalManaging Director/General Partner1999 — 2013San Francisco Bay Area
  10. Millennium PharmaceuticalsDirector, Business Development1996 — 1997Cambridge, MA
  11. TularikManager, Business Development1992 — 1996South San Francisco, CA

Education

  1. MIT Sloan School of ManagementMaster of Business Administration (MBA), Business Administration and Management1990 — 1992
  2. Harvard Medical SchoolMaster of Science (M.S.), Genetics1985 — 1990
  3. Boston UniversityBachelor of Arts (B.A.), Biology1978 — 1983

Skills & more

Strategy22Strategic Planning11Relationship Building5Biotechnology99Entrepreneurship99Venture Capital99Start-ups77Commercialization70Lifesciences61Corporate Development43Life Sciences62Pharmaceutical Industry37
+12 moreMergers & AcquisitionsTechnology TransferBusiness DevelopmentPrivate EquityStrategic PartnershipsDue DiligenceDrug DiscoveryDrug DevelopmentAngel InvestingStart-up VenturesCapital RaisingVenture Financing

From Karl's professional profile.

Frequently asked questions

Where does Karl Handelsman work?
Karl Handelsman is Founder and Managing Partner at Codon Capital and Founder at Bonum Therapeutics.
What check size does Karl Handelsman write?
Karl Handelsman typically writes checks of $100K – $5M.
What companies did Karl Handelsman found?
Karl Handelsman founded Bonum Therapeutics.

Same school

Also attended MIT Sloan School of Management488

Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOlaInvestor at Investinor

+ 482 more

Also attended Harvard Medical School135

Niko BonatsosInvestment Team at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital

+ 129 more

Also attended Boston University249

Aydin SenkutFounder & Managing Partner at FelicisVinnie LauriaFounding Partner at Golden Gate VenturesGil GorenPartner at 83NorthJames LindenbaumCo-founder at HeavybitDave BiscegliaVenture Partner at Founder CollectiveKatherine OgnibeneOperations Associate at Founder Collective

+ 243 more

Shared employers

Also worked at UCSF79

Logan HilleLife Sciences Analyst at CincyTechPaul JennyBoard Chair at CincyTechDavid KaufmanInvestor at Third Rock VenturesFrancisco GimenezInvestment Team at 8VCHani GoodarziFounder, Tahoe Therapeutics at Amplify PartnersMichael FischbachBio Advisor at Amplify Partners

+ 73 more

Also worked at Life Science Angels13

John Kojiro MoriwakaVenture Partner - Japan at Mendoza VenturesAnne DeGheestMentor Capitalist, Investor & Corporate Advisor at Joyance PartnersCraig HardingInvestor at Sand Hill AngelsLeung KwokInvestor at Sand Hill AngelsMary GuanInvestor at Sand Hill AngelsPaul McEwanScientific Advisor at Time BioVentures

+ 7 more

Also worked at Genentech95

David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures

+ 89 more

Also worked at Millennium Pharmaceuticals27

David SchenkeinInvestor at GV (Google Ventures)Kevin MunnellyInvestor at Third Rock VenturesJohn KeiltyVenture Partner at Third Rock VenturesKevin GillisPartner and Chief Operating Officer at Third Rock VenturesNeil ExterRetired Partner at Third Rock VenturesRobert TepperPartner and co-founder of Third Rock Ventures

+ 21 more